|
|
Volumn 110, Issue 6, 2007, Pages 1248-1254
|
|
Neoadjuvant docetaxel treatment for locally advanced prostate cancer: A clinicopathologic study
a
|
|
Author keywords
Docetaxel; Neoadjuvant systemic therapy; Prostate specific antigen; Prostatic carcinoma
|
|
Indexed keywords
2 METHYLACYL COENZYME A RACEMASE;
BETA TUBULIN;
BETA TUBULIN I;
BETA TUBULIN III;
CYCLIN D1;
DOCETAXEL;
KI 67 ANTIGEN;
PROSTATE SPECIFIC ANTIGEN;
PROTEIN BCL 2;
PROTEIN P21;
PROTEIN P27;
PROTEIN P53;
UNCLASSIFIED DRUG;
ADULT;
AGED;
APOPTOSIS;
ARTICLE;
CANCER ADJUVANT THERAPY;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE MARKER;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
PROSTATECTOMY;
PROTEIN EXPRESSION;
SEMINAL VESICLE;
AGED;
ANTINEOPLASTIC AGENTS;
HUMANS;
IMMUNOHISTOCHEMISTRY;
MALE;
MICROARRAY ANALYSIS;
MIDDLE AGED;
NEOADJUVANT THERAPY;
PATIENT SELECTION;
PROSTATE-SPECIFIC ANTIGEN;
PROSTATECTOMY;
PROSTATIC NEOPLASMS;
TAXOIDS;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 34548740289
PISSN: 0008543X
EISSN: 10970142
Source Type: Journal
DOI: 10.1002/cncr.22897 Document Type: Article |
|
Times cited : (53)
|
|
References (6)
|
